Today: 19 May 2026
Tesla (TSLA) stock price climbs ahead of Nvidia earnings as Autopilot lawsuits return to focus
25 February 2026
2 mins read

Tesla (TSLA) stock price climbs ahead of Nvidia earnings as Autopilot lawsuits return to focus

NEW YORK, Feb 25, 2026, 10:03 (ET) — Regular session underway.

Tesla (TSLA.O) climbed 2.1% to $417.87 by 9:47 a.m. ET, up from its $409.38 finish on Tuesday. Even so, shares remain roughly 7% lower for the year.

This shift packs a punch: Tesla’s behaving like a classic high-beta tech play once more—equal parts carmaker, autonomy bet, and robotics story. As soon as the AI sector calms, buyers tend to jump back into Tesla, messy news cycle or not.

Nvidia’s quarterly numbers, landing after Wednesday’s closing bell, have turned into the next big test for the “Magnificent Seven”—that list includes Tesla. “Nvidia’s earnings matter because they are kind of the linchpin of the Mag Seven,” said Chuck Carlson at Horizon Investment Services. Over at Slatestone Wealth, Ken Polcari argued AI will “continue to disrupt the world,” but added, “I don’t think it’s the end of the world.” Reuters

Tesla has reignited its dispute with California regulators over the way it advertises its automated driving features. The company is taking the California Department of Motor Vehicles to court, aiming to reverse a ruling that said Tesla was misleading consumers, according to TechCrunch. The DMV decided last week not to pull Tesla’s licenses after the company dropped the word “autopilot” from its marketing in California. Tesla’s description says “Autopilot” manages highway acceleration, braking, and lane-keeping, while “Full Self-Driving” adds lane changes and traffic signal response on city streets—though drivers still need to supervise. TechCrunch

A federal judge in San Francisco on Tuesday allowed a class action to move forward against Tesla, which stands accused of favoring foreign hires to cut labor costs and discriminating against U.S. citizens. Still, the judge expressed doubts about the software engineer bringing the suit, casting skepticism on the chances of success. The case centers on claims of a so-called “H1B only” hiring track—referring to the H-1B visa program for highly skilled foreign talent. Reuters

The legal landscape is running headlong into the auto industry’s drive for “eyes-off” Level 3 autonomy, where drivers can let the car handle things—until it tells them to get back on the wheel. “We can start saving them time immediately, and do it in a very affordable way,” Ford’s Doug Field said. But Bosch’s Paul Thomas isn’t convinced: “We don’t know if Level 3 ever makes financial sense.” Former Waymo chief John Krafcik was even more blunt: “the juice isn’t worth the squeeze.” Tesla’s Full Self-Driving tech still sits at Level 2, so drivers need to keep watching, but Elon Musk’s company has already rolled out a limited robotaxi service, aiming to bring it to a few more U.S. cities by the first half of 2026—setting up a head-to-head with Alphabet’s Waymo. Reuters

Analysts aren’t on the same page. GLJ Research stuck with its sell rating on Tesla this week, keeping that $25.28 target. In a note cited by Investing.com, the firm said markets remain far too bullish on what Tesla’s Optimus robot can actually deliver.

Yet with this stock, the threat lingers: autonomy risk is, at its core, legal risk. Just last week, a federal judge shot down Tesla’s bid to toss out a $243 million jury verdict stemming from a deadly 2019 accident involving Autopilot in a Model S. Tesla, for its part, is likely to appeal.

Market focus now shifts to Nvidia. The chipmaker reports after the U.S. close on Wednesday. Traders are keyed in on its results and forward guidance—any misstep or fresh optimism could either jolt or deflate the AI-driven run in tech-heavy stocks.

Stock Market Today

  • Ito En Shares Slide 10% in Year Despite Revenue Growth; Valuation Called Overpriced
    May 18, 2026, 10:51 PM EDT. Ito En (TSE:2593) stock declined about 10% over the past year with a 5% drop in the last month, reflecting fading momentum despite positive revenue and net income growth. The company trades at a high price-to-earnings (P/E) ratio of 123.4x, significantly above its fair value estimate of 71.8x and the Asian Beverage industry average of 18.9x. This elevated P/E suggests investor expectations for strong future profit growth, even as recent earnings were hit by a ¥15.3 billion one-time loss, reducing profit margins to 0.5% from 2.7%. Discounted cash flow (DCF) models also indicate the current share price may be overvalued, with a fair value around ¥1,561.46 per share compared to the closing price near ¥2,892.5. Investors should consider valuation risks amid mixed signals on Ito En's growth outlook.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Apple stock ticks up after shareholders reject “China audit” proposal; Nvidia earnings in view
Previous Story

Apple stock ticks up after shareholders reject “China audit” proposal; Nvidia earnings in view

Sandisk stock price steadies after Citron short call; Bernstein talk looms for SNDK
Next Story

Sandisk stock price steadies after Citron short call; Bernstein talk looms for SNDK

Go toTop